Evidence map›Paper›PMID 26268783›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2016

Safety and tolerability of Kinesio Taping in patients with arm lymphedema: medical device clinical study.

Jacqueline de Carvalho Martins, Suzana Sales Aguiar, Erica Alves Nogueira Fabro, Rejane Medeiros Costa, Thiago Vilela Lemos, Vinicius Gienbinsky Guapyassú de Sá, Raphael Mello de Abreu, Mauro Figueiredo Carvalho de Andrade, Luiz Claudio Santos Thuler, Anke Bergmann

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Linfotaping with Kinesio® Tape to manage and treat lymphedema patients: safety and tolerability are more important than efficacy?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Article
  7. Comment on "Linfotaping with kinesio® tape to manage and treat lymphedema patients: safety and tolerability are more important the efficacy?".Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Article
  8. Comment on "Safety and tolerability of Kinesio® Taping in patients with arm lymphedema: medical device clinical study".Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Jacqueline de Carvalho MartinsRehabilitation Sciences Master's Program, Augusto Motta University Center, Rio de Janeiro, Brazil. jacmestrado@gmail.com.
Suzana Sales AguiarClinical Epidemiology Program, National Cancer Institute, Rio de Janeiro, Brazil. saguiar@inca.gov.br.
Erica Alves Nogueira FabroPhysiotherapy Service, Cancer Hospital III, National Cancer Institute, Rio de Janeiro, Brazil. efabro@inca.gov.br.
Rejane Medeiros CostaPhysiotherapy Service, Cancer Hospital III, National Cancer Institute, Rio de Janeiro, Brazil. rejane.costa@inca.gov.br.
Thiago Vilela LemosBrasilia University, Universidade de Goiás, Rio de Janeiro, Brazil. tvlemos@gmail.com.
Vinicius Gienbinsky Guapyassú de Sá, Rio de Janeiro, Brazil. vinicius.guapyassu@hotmail.com.
Raphael Mello de Abreu, Rio de Janeiro, Brazil.
Mauro Figueiredo Carvalho de AndradeMedicine School, São Paulo University, São Paulo, Brazil. mauroand@uol.com.br.
Luiz Claudio Santos ThulerClinical Epidemiology Program, National Cancer Institute, Rio de Janeiro, Brazil. lthuler@inca.gov.br.
Anke BergmannClinical Epidemiology Program, National Cancer Institute, Rua André Cavalcanti, 37 / 2o andar - Centro, Rio de Janeiro, RJ, 20231-050, Brazil. abergmann@inca.gov.br.
Hospital do Câncer III · BRInstituto Nacional do Câncer · BRNational Cancer Institute · MYUniversidade de São Paulo · BRUniversidade Federal de Goiás · BRUniversity Center Augusto Motta · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study is to assess the safety and tolerability of Kinesio Taping (KT) in patients with arm lymphedema.

methodMedical device clinical study in women with arm lymphedema. Kinesio Tex Gold bandage was applied by the KT technique. Assessments and interviews were carried out both at the beginning and 4 days after intervention. Skin disorders, reported tolerance and modification of limb volume and function after intervention were assessed. Changes in limb volume and functionality before and after intervention were compared by the Student's t test and the Wilcoxon Signed-Rank test, considering significant p value <0.05.

resultsTwenty-four women were studied. After intervention, no patient had cutaneous lesions, vesicle or limb hyperthermia, and 4.2% presented skin peeling and redness. Most patients reported no change in social life and that they felt safer in the daily activity and were very pleased with the treatment. The patients presented improvement of upper limb functionality after intervention (p < 0.001). No difference of limb volume was found after intervention (p = 0.639).

conclusionsKinesio Tex Gold bandage by the KT technique proved to be safe and tolerable in patients with lymphedema, with improved functionality and no change of the affected limb volume.

Indexed as

AdultArmBandagesBreast NeoplasmsFemaleHumansLymphedemaMiddle AgedPhysical Therapy ModalitiesBandageBreast cancerKinesio TapingLymphedemaPhysiotherapy

Identifiers

PMID26268783
OpenAlexW1129084902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.